Remove contact
article thumbnail

Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule

Healthcare Law Blog

Some concerns and reasons noted by the DEA for extending the telemedicine flexibilities include: Reductions in access to care for patients who may not have an established practitioner-patient relationship; Practitioner backlogs for providing in-person medical evaluations; and Urgent public health needs for certain controlled medications.

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

These and other impediments are remnants of the “war on drugs” and are both the product of and the nourishment for moral defect judgments that perpetuate stigma against people with OUD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

For more information about the Temporary Rule, please contact: Chris Eades at (317) 977-1460 or ceades@hallrender.com ; Todd Nova at (414) 721-0464 or tnova@hallrender.com ; Mayo Alao at (317) 977-1480 or malao@hallrender.com or Your primary Hall Render contact.

article thumbnail

HHS Announces 42 Part 2 Final Rule to Align with HIPAA

Healthcare Law Blog

Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) recently released the long anticipated Final Rule to revise the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 C.F.R. Part 2 (Part 2). 290dd-2(a). [2]

HIPAA 52
article thumbnail

Senate Committee’s PREVENT Pandemics Act Draft Released: What to Know

Healthcare Law Today

Stakeholders interested in submitting comments to the HELP Committee, or seeking additional information on the PREVENT Pandemics Act or related measures, should contact Jennifer Walsh, Director of Public Affairs with Foley & Lardner at jwalsh@foley.com or (202) 295-4762. Sources: Senate Press Release and PDF

article thumbnail

Proposed Changes to the Confidentiality of Substance Use Disorder Patient Records Regulations

Hall Render

On December 2, 2022, the Department of Health and Human Services (“HHS”) Substance Abuse and Mental Health Services Administration (“SAMHSA”) released a proposed rule modifying the Confidentiality of Substance Use Disorder Patient Records regulations at 42 CFR Part 2 (“Part 2”). Your primary Hall Render contact.

HIPAA 75
article thumbnail

Medicare Physician Fee Schedule for 2023: What Providers Need to Know

Hall Render

Additionally, CMS is allowing periodic assessments to be furnished audio-only when video is not available for the duration of CY 2023 when certain regulatory requirements (namely, those of the Substance Abuse and Mental Health Services Administration (“SAMHSA”) and the Drug Enforcement Administration (“DEA”) are met.